With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower ...

The FDA approved the monoclonal antibody clesrovimab-cfor for the prevention of respiratory syncytial virus lower respiratory ...

Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

The CDC’s Advisory Committee on Immunization Practices is expected to meet later in June to issue recommendations for use.

The feud between Secret Lives of Mormon Wives costars Whitney Leavitt and Mikayla Matthews just got very messy, courtesy of ...

As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...

Robert F. Kennedy Jr.’s removal of all remaining members of the CDC’s Advisory Committee on Immunization Practices raises ...

The Food and Drug Administration (FDA) has approved Enflonsia ™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who ...

The CDC approves an RSV vaccine for infants, and a new survey reveals how much Americans would pay for a day of peace and quiet.

Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...

RSV hospitalization increases the likelihood of cardiovascular events, dysrhythmias or heart failure more than COVID-19 hospitalization.